BE900332A - Traitement de l'endometriose. - Google Patents
Traitement de l'endometriose.Info
- Publication number
- BE900332A BE900332A BE0/213474A BE213474A BE900332A BE 900332 A BE900332 A BE 900332A BE 0/213474 A BE0/213474 A BE 0/213474A BE 213474 A BE213474 A BE 213474A BE 900332 A BE900332 A BE 900332A
- Authority
- BE
- Belgium
- Prior art keywords
- endometriosis
- treatment
- progestogen
- pharmaceutical composition
- excipient
- Prior art date
Links
- 201000009273 Endometriosis Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 239000000583 progesterone congener Substances 0.000 abstract 2
- 241000289695 Eutheria Species 0.000 abstract 1
- 101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 abstract 1
- 102100024028 Progonadoliberin-1 Human genes 0.000 abstract 1
- 101000996723 Sus scrofa Gonadotropin-releasing hormone receptor Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- XLXSAKCOAKORKW-UHFFFAOYSA-N gonadorelin Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 abstract 1
- HCFSGRMEEXUOSS-JXEXPEPMSA-N medrogestone Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(C)[C@@]1(C)CC2 HCFSGRMEEXUOSS-JXEXPEPMSA-N 0.000 abstract 1
- 229960000606 medrogestone Drugs 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Conditionnement pour l'administration simultanée ou séquencée dans le traitement de l'endométriose chez la femelle d'un mammifère placentaire, caractérisé en ce qu'il comprend une première composition pharmaceutique comprenant de la LHRH ou un agoniste de celle-ci et un excipient pharmaceutiquement acceptable, et une seconde composition pharmaceutique comprenant un agent progestatif et un excipient pharmaceutiquement acceptable, étant entendu que l'agent progestatif est autre que la médrogestone.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52178683A | 1983-08-09 | 1983-08-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE900332A true BE900332A (fr) | 1985-02-11 |
Family
ID=24078156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/213474A BE900332A (fr) | 1983-08-09 | 1984-08-09 | Traitement de l'endometriose. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0136781A3 (fr) |
| JP (1) | JPS60120820A (fr) |
| BE (1) | BE900332A (fr) |
| DE (1) | DE3429261A1 (fr) |
| IT (1) | IT1206129B (fr) |
| PH (1) | PH20266A (fr) |
| ZA (1) | ZA845550B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3518252A1 (de) * | 1985-05-21 | 1986-11-27 | Dirck Dr.med. 6500 Mainz Oppermann | Nasal zu applizierendes mittel zur bekaempfung maennlicher und weiblicher infertilitaet |
| WO1988001176A1 (fr) * | 1986-08-18 | 1988-02-25 | Bunge (Australia) Pty. Ltd. | Regulation de la reproduction animale |
| US5130137A (en) * | 1989-08-09 | 1992-07-14 | The General Hospital Corporation | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders |
| DE60325275D1 (de) * | 2003-02-07 | 2009-01-22 | Austria Wirtschaftsservice Gmbh | Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen |
| IT201900019876A1 (it) * | 2019-10-28 | 2021-04-28 | Ilaria Napoletano | Serrapeptasi per uso nel trattamento di endometriosi profonda. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2465486A1 (fr) * | 1979-09-21 | 1981-03-27 | Roussel Uclaf | Nouvelle application utilisant la lh-rh ou des agonistes |
-
1984
- 1984-07-18 ZA ZA845550A patent/ZA845550B/xx unknown
- 1984-07-31 EP EP84305204A patent/EP0136781A3/fr not_active Withdrawn
- 1984-07-31 IT IT8422144A patent/IT1206129B/it active
- 1984-08-06 PH PH31075A patent/PH20266A/en unknown
- 1984-08-08 DE DE19843429261 patent/DE3429261A1/de not_active Withdrawn
- 1984-08-09 BE BE0/213474A patent/BE900332A/fr not_active IP Right Cessation
- 1984-08-09 JP JP59167706A patent/JPS60120820A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PH20266A (en) | 1986-11-14 |
| IT8422144A0 (it) | 1984-07-31 |
| JPS60120820A (ja) | 1985-06-28 |
| EP0136781A2 (fr) | 1985-04-10 |
| DE3429261A1 (de) | 1985-02-21 |
| EP0136781A3 (fr) | 1986-06-04 |
| ZA845550B (en) | 1986-03-26 |
| IT1206129B (it) | 1989-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE849632A (fr) | Composition pharmaceutique pour l'administration orale | |
| EP0783299A4 (fr) | Composes et compositions pour l'administration d'agents actifs | |
| FR2622798B1 (fr) | Forme d'apport dose et dispositif osmotique d'administration d'un medicament pour le traitement de maladies cardio-vasculaires | |
| FR2565829B1 (fr) | Dispositif pour l'administration des medicaments sous forme de poudres | |
| FR2523443B1 (fr) | Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique | |
| BE884640A (fr) | Dispositif de raccordement rotatif pour ensemble d'administration intraveineuse | |
| DZ1077A1 (fr) | Nouvelles préparation pharmaceutique pour administration orale. | |
| BE837472A (fr) | Inhalateur pour l'administration de remedes pulverulents | |
| DE3171774D1 (en) | Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom | |
| FR2502951B1 (fr) | Compositions pharmaceutiques topiques sous forme d'une micro-emulsion | |
| HU896428D0 (en) | Process for the preparation of imidazoles and pharmaceutical compositions thereof | |
| BE845613A (fr) | Preparations pharmaceutiques pour l'administration orale renfermant un ester-17beta de nandrolone et nouveaux esters- 17beta de nandrolone | |
| FR2560044B1 (fr) | Dispositif therapeutique osmotique pour l'apport de medicaments | |
| GB1390803A (en) | Medicinal tampons and compositions containing lactulose | |
| NO880179D0 (no) | Polymerkomplekser, fremgangsmaate for fremstilling av disse, og farmasoeytiske midler inneholdende disse. | |
| BE900332A (fr) | Traitement de l'endometriose. | |
| FR2660192B1 (fr) | Formulation liposomiales pour l'administration topique ou vaginale de medicaments. | |
| GB1491503A (en) | Method of preventing and treating thrombosis | |
| GB1341794A (en) | Medicament for the treatment of hepatic disorders | |
| BE887639A (fr) | Compositions pharmaceutiques pour le traitement de l'hyperplasie prostatique benigne | |
| EP0106812A3 (en) | Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor, useful for the treatment of the myocardium infarction | |
| FR2714603B1 (fr) | Composition dermatologique et son utilisation pour la préparation d'un médicament. | |
| HU9302813D0 (en) | Pharmaceutical compositions containing new benzimidazole derivatives and process for preparing the active ingredients | |
| BE872908A (fr) | Compositions pharmaceutiques pour le traitement de l'hypertension | |
| GB1483650A (en) | Pharmaceutical preparations based on mesterolone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: AMERICAN HOME PRODUCTS CORP. Effective date: 19880831 |